ZA200301139B - The treatment of inflammatory disoders. - Google Patents

The treatment of inflammatory disoders. Download PDF

Info

Publication number
ZA200301139B
ZA200301139B ZA200301139A ZA200301139A ZA200301139B ZA 200301139 B ZA200301139 B ZA 200301139B ZA 200301139 A ZA200301139 A ZA 200301139A ZA 200301139 A ZA200301139 A ZA 200301139A ZA 200301139 B ZA200301139 B ZA 200301139B
Authority
ZA
South Africa
Prior art keywords
mefloquine
treatment
disease
inflammatory
erythro
Prior art date
Application number
ZA200301139A
Other languages
English (en)
Inventor
Benjamin Mark Skead
Robin Mark Bannister
Alan Rothaul
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of ZA200301139B publication Critical patent/ZA200301139B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200301139A 2000-09-05 2003-02-11 The treatment of inflammatory disoders. ZA200301139B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0021776.0A GB0021776D0 (en) 2000-09-05 2000-09-05 The treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
ZA200301139B true ZA200301139B (en) 2004-03-29

Family

ID=9898880

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200301139A ZA200301139B (en) 2000-09-05 2003-02-11 The treatment of inflammatory disoders.

Country Status (21)

Country Link
US (2) US7034028B2 (pl)
EP (1) EP1315496B1 (pl)
JP (1) JP2004508323A (pl)
CN (1) CN1309388C (pl)
AT (1) ATE302008T1 (pl)
AU (2) AU2001284234B2 (pl)
BR (1) BR0113646A (pl)
CA (1) CA2419601A1 (pl)
DE (1) DE60112768T2 (pl)
DK (1) DK1315496T3 (pl)
ES (1) ES2245372T3 (pl)
GB (1) GB0021776D0 (pl)
HU (1) HUP0300934A2 (pl)
IL (1) IL154419A0 (pl)
MX (1) MXPA03001920A (pl)
NO (1) NO323227B1 (pl)
NZ (1) NZ524099A (pl)
PL (1) PL364030A1 (pl)
PT (1) PT1315496E (pl)
WO (1) WO2002019994A2 (pl)
ZA (1) ZA200301139B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders
GB0406014D0 (en) * 2004-03-17 2004-04-21 Arakis Ltd Pharmaceutical composition and use
WO2006108666A1 (en) * 2005-04-13 2006-10-19 Proteosys Ag Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
US20100144827A1 (en) * 2006-12-20 2010-06-10 Medwell Laboratories Ltd. C/O Ngt Technological Incubator Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
CA2804666A1 (en) * 2010-07-07 2012-01-12 Polymedix, Inc. Methods of immune modulation
CN113578299B (zh) * 2020-04-30 2023-11-10 中国石油化工股份有限公司 一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) * 2020-12-31 2023-06-09 兰州大学 喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) * 2022-01-04 2022-07-29 南京医科大学 甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633499B2 (en) * 1988-06-30 1993-02-04 Michael H. Davis Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
CZ285937B6 (cs) * 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
ATE169009T1 (de) * 1994-03-09 1998-08-15 Pfizer Isoxazoline verbindung zur hemmung tnf-freigabe
AU730818B2 (en) 1997-03-07 2001-03-15 Vernalis Research Limited Use of (+)mefloquine for the treatment of malaria
EP0975345A1 (en) 1997-11-26 2000-02-02 Cerebrus Pharmaceuticals Limited (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
JP2002543122A (ja) 1999-04-30 2002-12-17 エイピーティー ファーマスーティカルズ エルエルスィー 抗マラリア治療剤についての新規使用
GB0021776D0 (en) * 2000-09-05 2000-10-18 Arakis Ltd The treatment of inflammatory disorders

Also Published As

Publication number Publication date
CN1309388C (zh) 2007-04-11
ATE302008T1 (de) 2005-09-15
WO2002019994A3 (en) 2002-05-16
BR0113646A (pt) 2004-01-06
US7034028B2 (en) 2006-04-25
EP1315496A2 (en) 2003-06-04
NO20030985L (no) 2003-03-03
WO2002019994A2 (en) 2002-03-14
JP2004508323A (ja) 2004-03-18
AU2001284234B2 (en) 2004-11-04
MXPA03001920A (es) 2004-02-12
DE60112768D1 (de) 2005-09-22
EP1315496B1 (en) 2005-08-17
CA2419601A1 (en) 2002-03-14
HK1054324A1 (en) 2003-11-28
GB0021776D0 (en) 2000-10-18
US20040029916A1 (en) 2004-02-12
US20060074106A1 (en) 2006-04-06
DK1315496T3 (da) 2005-11-14
PL364030A1 (pl) 2004-12-13
CN1452488A (zh) 2003-10-29
IL154419A0 (en) 2003-09-17
HUP0300934A2 (hu) 2003-11-28
NZ524099A (en) 2004-04-30
AU8423401A (en) 2002-03-22
ES2245372T3 (es) 2006-01-01
NO20030985D0 (no) 2003-03-03
PT1315496E (pt) 2005-11-30
NO323227B1 (no) 2007-02-05
DE60112768T2 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
JP5086322B2 (ja) Ｍｃｐ−１プロテインの増加生産によって特徴付けられる障害の処置のための薬剤組成物
KR100358373B1 (ko) 9-하이드록시리스페리돈지방산에스테르의수성현탁액
TNSN05037A1 (fr) Derives heterobiaryliques servant d'inhibiteurs de metalloproteinases de matrice
WO1992002220A1 (en) Tnf inhibitors
EP1315496B1 (en) The treatment of inflammatory disorders
AU2001284234A1 (en) The treatment of inflammatory disorders
CZ285633B6 (cs) Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek
US20020128317A1 (en) Treatment of pathological conditions characterized by an increased IL-1 level
RU2275906C2 (ru) Средство для лечения болезни паркинсона, включающее в качестве активного ингредиента соединение, улучшающее астроцитную функцию
HK1054324B (en) The treatment of inflammatory disorders
US20040220221A1 (en) Treatment of degenerative diseases
US6191158B1 (en) Pharmaceutical composition active in reducing production of MCP-1 protein
US20070202503A1 (en) Pharmaceutical Composition Of (+)-Erythro-Mefloquine And Its Use
CA2696703A1 (en) Treatment of sleep disorders